Xlife Sciences AG Stock price BOERSE MUENCHEN

Equities

XLS

CH0461929603

Biotechnology & Medical Research

Real-time BOERSE MUENCHEN 01:43:00 2022-02-10 pm EST 5-day change 1st Jan Change
41.8 EUR -0.48% Intraday chart for Xlife Sciences AG -7.52% -3.69%

Financials

Sales 2023 * 800K 887K 820K Sales 2024 * 800K 887K 820K Capitalization 258M 286M 264M
Net income 2023 * -4M -4.44M -4.1M Net income 2024 * -4M -4.44M -4.1M EV / Sales 2023 * 402 x
Net Debt 2023 * 63.9M 70.86M 65.51M Net Debt 2024 * 65.2M 72.31M 66.84M EV / Sales 2024 * 404 x
P/E ratio 2023 *
-62.8 x
P/E ratio 2024 *
-68.5 x
Employees 13
Yield 2023 *
-
Yield 2024 *
-
Free-Float 47.79%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.48%
Current month-3.69%
Current year-3.69%
More quotes
3 years
41.80
Extreme 41.8
60.00
5 years
24.00
Extreme 24
60.00
10 years
24.00
Extreme 24
60.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 19-06-30
Director of Finance/CFO - 21-11-30
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Compliance Officer - 19-09-11
Director/Board Member - 18-10-24
Chief Executive Officer - 19-06-30
More insiders
Xlife Sciences AG is a Switzerland-based biotechnology company. The Company focuses on investing in technologies in the life science industry. It supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The Company offers its investors direct access to the further development of technologies at a very early stage. The Company cooperates with industrial partners and universities.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.2 CHF
Average target price
68 CHF
Spread / Average Target
+50.44%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Xlife Sciences AG
  4. Stock Xlife Sciences AG - BOERSE MUENCHEN